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Abstract
Background: Myelin transcription factor 1-like (MYT1L) is a member of the myelin transcription factor 1 (MYT1) gene family,
and the neural specific, zinc-finger-containing, DNA-binding protein that it encodes plays a role in the development of the
nervous system. On the basis of a recent copy number variation (CNV) study showing that this gene is disrupted in mental
disorder patients, we investigated whether MYT1L also plays a role in MDD.
Methods: In this study, 8 SNPs were analyzed in 1139 MDD patients and 1140 controls of Chinese Han origin.
Results: Statistically significant differences were noted between cases and controls for rs3748989 (allele: permutated
p=0.0079, corrected p=0.0048, genotype: corrected p=0.0204). A haplotype of rs1617213 and rs6759709 G-C was also
significant (permutated p=0.00007).
Conclusion: Our results indicate that MYT1L may be a potential risk gene for MDD in the Chinese Han population.
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Introduction
Major depressive disorder (MDD) is a common and severe
mental disorder with a prevalence of at least 10% in the general
population [1–2]. Although twin studies indicate only 40–50%
heritability in MDD, adoption studies indicate the role of genetic
factors [3]. Many candidate genes, such as SLC6A4 and 5HTR2A,
have been associated with MDD in recent decades [2]. A number
of genes have also been identified as being common to several
psychotic disorders such as schizophrenia (SCZ) and bipolar
disorder (BP) [4]. The classic example is DISC1, which is linked to
both SCZ and MDD [5].
The gene myelin transcription factor 1-like (MYT1L, also known
as NZF1) is located on chromosome 2p25.3. The gene spans
542081 bp, and has 25 exons. Exon 1 to exon 5 and the distal part
of exon 25 are untranslated regions (UTRs), while the other 19
exons and the proximal part of exon 25 are coding regions.
MYT1L is a member of the myelin transcription factor 1 (MYT1)
gene family. These genes encode a family of neural specific, zinc-
finger-containing DNA-binding proteins, which play a role in the
development of the nervous system. In a recent copy number
variation (CNV) study, MYT1L along with 3 other candidate genes
was found to be disrupted in SCZ patients [6].
In this case-control study, we sought to determine whether
MYT1L is associated with MDD.
Materials and Methods
1 Ethics Statement
T h ec o m p l e t ed e t a i l so ft h ee n t i r es t u d yd e s i g na n dp r o c e d u r e s
involved were submitted to the ethics committee of Bio-X center
Shanghai Jiaotong University. After approval was obtained, we
initiated this research in accordance with the defined protocols. Each
participant was clearly explained about the procedure and purpose of
this study. Written informed consent for this genetic study was given
by each participant. All data were recorded anonymously but if the
participants requested to withdraw their file, the data were destroyed.
2 Subjects
The patients and controls recruited in this study were
biologically unrelated and all were of the Han Chinese ethnicity
and belonged to the local Shanghai population. We enrolled 1139
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female patients). All patients were treated at the same clinic, and
the two-year case history of each patient was analyzed to ensure
that he/she did not have a bipolar tendency. In this study, all the
patients recruited had severe depressive symptoms. All patients
were assessed by using the Structured Clinical Interview for DSM
disorders. All the patients had a sole diagnosis of depression, and
some had additional features of anxiety. We included only patients
with Hamilton Depression Rating Scale (HAMD) scores greater
than 20. Cases with high HAMD scores could be thought of as a
subtype of depressive disorder. The control group consisted of
1140 randomly selected normal individuals (374 males and 766
females). The average age of onset of MDD was 35.1 (611.6)
years, and the average age of the controls was 58.7 (69.9) years.
All the patients were interviewed by 2 independent psychiatrists
and were diagnosed strictly according to the DSM-IV criteria.
Patients who had organic disorders were excluded from the study.
Controls were recruited from among volunteers randomly selected
from local Shanghai communities. All the controls gave informed
consent and were local citizens with both their parents belonging
to Shanghai and no family history of psychiatric disorders. Written
informed consent for this genetic study was provided by each
participant. The demographic characteristics of the study
population are listed in table 1.
3 Genotyping
There are 25 exons in MYT1L. Exon 1 to exon 5 and the distal
part of exon 25 are untranslated regions (UTRs), while the other
19 exons and the proximal part of exon 25 are coding regions. We
focused on the region extending from exon 6 to exon 24. We
selected tag SNPs using the software Haploview 4.1, with minor
allele frequency (MAF) $0.2 and r
2$0.5 in the Han Chinese
population in Beijing. Due to the non-availability of allele
frequency data of many markers for the CHB population, we
only found 2 in coding regions (exon 9). Then we selected others
with a view to obtaining uniform coverage of the coding regions.
Finally, we chose 8 tag SNPs (rs1617213, rs6759709, rs6727410,
rs11687068, rs3748989, rs3748988, rs4305302, and rs7592630)
for genotyping. These SNPs span the region where most exons are
located. Except for rs3748989 and rs3748988, which are located
in exon 9, the markers are all intronic SNPs (the location of these
SNPs and exons of MYT1L are displayed in Fig. 1). We tested our
SNP variability by using a web tool provided by the Broad
Institute http://www.broadinstitute.org/mpg/tagger/server.html
[7]. On performing this test with r
2$0.5 and MAF $0.2, our
markers could capture 54% of the variability in the whole region.
We performed genotyping using the ABI 7900 DNA detection
system (Applied Biosystems, Foster City, California) with Taq-
ManH probes supplied by Applied Biosystems. Every assay was
tested twice in 32 samples during the preliminary experiments.
The results of these duplicate samples were completely consistent
(100%). The standard 5-ml polymerase chain reaction (PCR)
reaction was carried out using TaqManH Universal PCR Master
Mix reagent kits according to the protocol recommended by the
manufacturer.
4 Statistical analysis
Odds ratios, allele frequency, and genotypic association were
calculated by using http://analysis.bio-x.cn [Shi and He 2005].
This is a user friendly platform that integrates analysis tools
especially suited to association studies. We used Haploview 4.1 [8]
to estimate the Hardy–Weinberg equilibrium, linkage disequilib-
rium, and allelic and haplotype distribution. For precise results, p
values of the alleles were permutated 100,000 times. To reduce the
type I error rate, we also ran the program SNPSpD [9], which
reflects the linkage disequilibrium among markers and correct p
values.
Results
We genotyped 8 SNPs on all the samples, and found that
deviation from the Hardy–Weinberg equilibrium was absent for all
cases and controls. MDD patients and controls showed statistically
significant differences for 3 SNPs in the allelic and genotypic
distribution (rs3748989, p=0.0008 for allele, p=0.0034 for
genotype; rs3748988, p=0.024 for allele, p=0.0051 for genotype;
rs7592630,p=0.0369forgenotype).Theresultsareshownintable2
and Supporting information –Table S1. Even after permutation on
Haploview and correction by SNPSpD (the effective number of tests
is 6), rs3748989 continued to be significantly associated with MDD
(for allele, permutated p=0.0079, corrected p=0.0048; for
genotype, corrected p=0.0204), and the genotypic frequency of
rs3748988 still remained significant (for genotype, corrected
p=0.0306). Power analysis was performed by using the software
GPower. The power was 0.9550452, with effect size d=0.14
[d=ln(or)/1.65], a=0.05 (odd’s ratio was for rs3748989).
Since there is a difference in the proportion of males and
females in our samples, we analyzed our data by using the PLINK
software with age and gender as covariables. After correction, the
p value was still smaller than 0.05. We also performed an
association analysis stratified by gender in Haploview 4.1. The p
values are still smaller than 0.05 in both gender groups.
The results of linkage disequilibrium analysis for these SNPs are
shown in Figs. 2 and 3. Block 1 and block 2 were in linkage
disequilibrium, with D’.0.6. Subsequent haplotype analysis for
these 2 blocks showed a notable association in block 1 (rs1617213
and rs6759709 G-C; permutated p=0.00007).
Discussion
In our study, we found 1 SNP in MYT1L to be associated with
MDD. The expression of the protein MYT1L, which is abundant
in the brain, has never been studied for allelic association in any
psychiatric disorder. However, in a genome-wide screen for CNVs
with SCZ patients, Vrijenhoek et al. identified 2 duplications—
MYT1L in the chromosomal region 2p25.3 and CTNND2 at
5p15.2. Both these genes were disrupted at their terminal portions
Table 1. Sociodemographic characteristics of the sample population.
Study sample Sample Size Mean Age (SD) Mean Age of Onset (SD) Male/Female Female %
MDD 1,139 36.2(12.8) 35.1(11.6) 484/655 57.2
Control 1,140 58.7(9.9) 349/791 67.2
MDD: major depressive disorder; SD: standard deviation.
doi:10.1371/journal.pone.0013662.t001
MYT1L Is Associated with MDD
PLoS ONE | www.plosone.org 2 October 2010 | Volume 5 | Issue 10 | e13662Figure 1. Exons of MYT1L, and eight tag SNPs we selected. This figure was created by software Vector NTI. The blue strips represent all the 25
exons of MYT1L. Since the whole length of gene MYT1L is 542081 bp and most exons are shorter than 400 bp and are closely located, the 25 exons
seem very closely located and crowded. The exons located by the same strip, such as exons 6 to 8, exons 12 to 13, exons 15 to 18, and exons 24 to 25,
have been enclosed in a dot line square. Exon 1 to exon 5 and the distal part of exon 25 are untranslated regions (UTRs), while the other 19 exons and
the proximal part of exon 25 are coding regions. Noncoding exons are showed in italics. The green dots identify the 8 SNPs selected from MYT1L, and
the arrow head points to their rs numbers. Markers rs3748988 and rs3748989 are located in exon 9, and the other 6 are located in introns. Exon 9 is
only 353-bp long and encodes a polypeptide of 119 amino acids.
doi:10.1371/journal.pone.0013662.g001
Table 2. Association analysis of 8 SNPs in the MYT1L gene among MDD patients and controls.
SNP ID MAF Allele Frequency Call Rates
Odds
Ratio p value
Permutated
p value
Pearson’s
p value
AG
rs1617213 MDD 0.256 1731(0.7818) 483(0.2182) 0.97 0.873 0.0706 0.4777 0.0974
Intron Control 1798(0.8041) 438(0.1959) 0.98
CT
rs6759709 MDD 0.256 479(0.2228) 1671(0.7772) 0.94 1.1273 0.1031 0.6139 0.2511
Intron Control 446(0.2027) 1754(0.7973) 0.96
AG
rs6727410 MDD 0.411 838(0.3813) 1360(0.6187) 0.96 0.9264 0.2456 0.9105 0.4616
Intron Control 886(0.3995) 1332(0.6005) 0.97
AG
rs11687068 MDD 0.356 1457(0.6599) 751(0.3401) 0.97 0.924 0.1946 0.8446 0.2412
Intron Control 1348(0.6774) 642(0.3226) 0.87
CT
rs3748989 MDD 0.222 1617(0.7707) 481(0.2293) 0.92 1.2653 0.0008 0.0079 0.0034
Exon 9 Control 1626(0.7265) 612(0.2735) 0.98
AG
rs3748988 MDD 0.411 970(0.4385) 1242(0.5615) 0.97 1.1461 0.024 0.2019 0.0051
Exon 9 Control 907(0.4053) 1331(0.5947) 0.98
CT
rs4305302 MDD 0.359 754(0.3481) 1412(0.6519) 0.95 0.984 0.7845 1.0000 0.114
Intron Control 769(0.3518) 1417(0.6482) 0.96
CT
rs7592630 MDD 0.411 1312(0.6102) 838(0.3898) 0.94 0.9136 0.1817 0.8222 0.0369
Intron Control 1359(0.6315) 793(0.3685) 0.94
MDD = major depressive disorder; SNP = single nucleotide polymorphism.
Odds ratio using SHEsis; p value using Haploview 4.1 and was permutated 100,000 times; Pearson’s p value using SHEsis is for genotype frequency.
doi:10.1371/journal.pone.0013662.t002
MYT1L Is Associated with MDD
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implicated in their study were NRXN1 and ASTN2. Each of these
genes showed 1 deletion each. NRXN1 has already been confirmed
to be associated with SCZ. Although no definite relationship
between the other 3 genes and mental disorders has yet been
established, it is known that all these genes play important roles in
neuronal function. CTNND2 catenin (cadherin-associated pro-
tein), delta 2 (neural plakophilin-related arm-repeat protein) is a
member of the beta-catenin superfamily, which is abundantly
present in neural tissue and is known to modulate neurite
outgrowth and synaptic activity[10]. Deletion of ASTN2 has been
associated with SCZ, and CNV of this gene was recently found in
patients with autism spectrum disorders (ASD) [11]. We suggest
that the MYT1L gene may also confer risk for MDD.
MYT1L is highly homologous to myelin transcription factor 1
(MYT1); the former maps to human chromosome 2, while the
latter maps to chromosome 20. Protein MYT1 is a representative
of the Cys-Cys-His-Cys (CCHC) zinc-finger protein family, which
has been highly conserved during evolution between both species
and family members. MYT3 is the third member of this family
[12]. Both MYT1 and MYT1L are widely expressed in developing
neuronal cells. MYT1L can only be detected in neurons at the
early stages of differentiation, but not in the glial lineage. This
suggests that MYT1L has a role in the development of the central
nervous system [13–14]. MYT1/MYT1L binding can result in the
recruitment of histone deacetylases (HDACs) to target gene
promoters, which results in transcriptional repression [15]; the
resultant loss of MYT1 function may be compensated by MYT1L
activity [16]. Although MDD in general is not classically
considered to be a neurodevelopmental in origin, severe MDD
has pervasive features that present in neurodevelopmental
disorders. The neurodevelopmental hypothesis of SCZ was
established 30 years ago and has been considered controversial
for a long time; this hypothesis postulated that pre- and perinatally
acting cerebral noxae caused disturbances of corticogenesis in the
developing neuronal fiber systems, which are responsible for the
later onset of the disease [17]. According to this hypothesis, an
unidentified event occurring in utero might disturb the normal
maturation of neuronal connections in SCZ patients [18]. David et
al. found an altered plasticity of the hippocampal structure in a
large proportion of the brains of SCZ patients [19]. Synaptic
rearrangement and plasticity were found to be related to the
expression of the embryonic form of neural cell adhesion molecule
(NCAM). David et al. also reported that these changes were caused
by the decrease in the levels of polysialylated NCAM. NCAM
isoforms in the brain were reported to be critical for many
neurodevelopmental processes, including neurulation, axonal
outgrowth, and the establishment of neuronal connectivity [19].
All these findings suggest that abnormalities and disturbances in
the development processes of the central nervous system might
lead to the appearance of mental disorders. Since the protein
MYT1L has been reported to play a role in the development of the
central nervous system, we think this protein may also play a
similar role in the pathogenesis of MDD.
This study represents the first attempt to test the association
between MYT1L and MDD. We recruited 1139 patients and 1140
controls and used 8 SNPs as tag markers to investigate the role
MYT1L in MDD patients of Chinese Han origin. The single
marker, rs3748989, located in exon 9 was found to be strongly
associated with MDD. Although this is a synonymous SNP, a
different allele may influence the efficiency of transcription, the
structural stability of transcripts, and the splicing signals [20],
which result in differences in its expression. We have submitted the
sequence of exon 9 with different allele in rs3748989 to RNAfold
Figure 2. D’ value for the 8 single nucleotide polymorphisms
(SNPs). D’ value between marker pairs is indicated by the shaded
matrices. This structure was created by Haploview 4.1. There were 2
linkage-disequilibrium blocks in the selected region. The SNPs
rs1617213 and rs6759709 were present in block 1. The SNPs
rs3748989, rs3748988, and rs4305302 were present in block 2.
doi:10.1371/journal.pone.0013662.g002
Figure 3. r
2 value for 8 single nucleotide polymorphisms
(SNPs). r
2 value between the marker pairs is indicated by the shaded
matrices. This structure was created by Haploview 4.1. There were 2
linkage-disequilibrium blocks in the selected region. The SNPs
rs1617213 and rs6759709 were present in block 1. The SNPs
rs3748989, rs3748988, and rs4305302 were in block 2. The SNPs
rs1617213 is not correlated with either rs3748989 or rs3748988, since
the r
2 values were only 0.018 and 0.064, respectively. r
2 values of
rs3748989 and rs3748988 is 0.247.
doi:10.1371/journal.pone.0013662.g003
MYT1L Is Associated with MDD
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There is an obvious difference in the minimum free energy
between allele A (243.53 kcal/mol) and allele G (259.63 kcal/
mol) of rs3748989. We think this difference may have an impact
on their secondary RNA structures during transcription. A
haplotype for rs1617213 and rs6759709 G-C was also significant,
but the significance of this remains unclear. In this study, we only
genotyped 8 markers; this is an obvious limitation of the study. We
suggest that more markers should be genotyped in subsequent
studies for a better mapping.
In summary, our results indicate that rs3748989 is probably
associated with MDD and that MYT1L may be a potential risk
gene for MDD in the Chinese Han population. To clarify the
relation between this gene and MDD, further studies with more
markers and cellular or protein expression experiments are
needed.
Supporting Information
Table S1 Details in association analysis of 8 SNPs in the
MYT1L gene among MDD patients and controls.
Found at: doi:10.1371/journal.pone.0013662.s001 (0.06 MB
DOC)
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